| Effects of acute and chronic infusion of islet amyloid polypeptide on food intake in rats. | |
| | |
MedLine Citation:
|
PMID: 8927946 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Islet amyloid polypeptide (IAPP), also called amylin, is a hormonal peptide produced by the islet beta-cells of the pancreas. Because the peptide is co-stored and co-released with insulin, attention has been focused on IAPP's ability to interfere with glucose metabolism. However, IAPP also has other effects, such as a reduction of food intake. METHODS: In this study we investigated the dose-response effect of acute systemic administration of rat and human IAPP on food intake, and the cumulative effect of chronically increased circulating IAPP concentrations on food intake and body weight in the rat. RESULTS: All doses of rat IAPP investigated acutely inhibited food intake. The lowest infusion rate of 8 pmol/kg/min caused an 28% inhibition of the food intake at 2 h (p < 0.05). No effect of human IAPP was observed. Chronic administration of rat IAPP via an osmotic minipump during a 6-day period caused prolonged inhibitory effects on food intake and reduced body weight. During the first 3 days of infusion the food intake of the IAPP group was only 44% of the food intake of the control group (p < 0.001). The body weight of the IAPP group had fallen 18.6 +/- 2.7 g by day 3, in contrast to a small increase in the control group (4.0 +/- 3.1 g; p < 0.001). The reduction in food intake was sustained throughout the last 3 days of study (IAPP, 16.7 +/- 1.1 g/day; control, 20.6 +/- 1.5; p < 0.05). Similarly, the body weight still differed at the end of day 6 and, compared with day 0, was -8.7 +/- 3.7 g for the IAPP group and +10.9 +/- 4.8 for the control group (p < 0.01). CONCLUSIONS: These findings show that chronic increase of circulating IAPP levels can cause a marked reduction in both food intake and body weight and, together with the reduced food intake seen after acute administration of the peptide, indicates the possibility of IAPP functioning as a satiety factor. |
| | |
Authors:
|
U Arnelo; J E Blevins; J Larsson; J Permert; P Westermark; R D Reidelberger; T E Adrian |
Related Documents
:
|
16469996 - Predictors of weight gain in a mediterranean cohort: the seguimiento universidad de nav... 6123956 - Effects of triethyltin on ingestive behavior at ad lib, reduced, and recovered body wei... 8833526 - Effects of diurnally cycling versus constant temperatures on chicken growth and food in... 16645296 - Food habits and intake of nutrients in elderly patients with parkinson's disease. 11770676 - Air pollution in asthma: effect of pollutants on airway inflammation. 1110296 - Nutritional knowledge, attitudes, and practices of high school graduates. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Scandinavian journal of gastroenterology Volume: 31 ISSN: 0036-5521 ISO Abbreviation: Scand. J. Gastroenterol. Publication Date: 1996 Jan |
Date Detail:
|
Created Date: 1996-10-25 Completed Date: 1996-10-25 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0060105 Medline TA: Scand J Gastroenterol Country: NORWAY |
Other Details:
|
Languages: eng Pagination: 83-9 Citation Subset: IM |
Affiliation:
|
Dept of Surgery, Linköping University, Sweden. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amyloid
/
pharmacology*,
physiology Animals Body Weight / drug effects Dose-Response Relationship, Drug Drug Evaluation, Preclinical Eating / drug effects* Infusions, Intravenous Male Rats Rats, Sprague-Dawley Satiety Response / drug effects Time Factors |
| Grant Support | |
ID/Acronym/Agency:
|
R0ICA44799/CA/NCI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Amyloid; 106602-62-4/amylin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Seasonal change in the exacerbations of Crohn's disease.
Next Document: Medium-chain triglyceride absorption in patients with pancreatic insufficiency.